We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

StemCells, Inc. Reports Positive Interim Data from Spinal Cord Injury Trial

News   Sep 06, 2012

 
StemCells, Inc. Reports Positive Interim Data from Spinal Cord Injury Trial
 
 
 

RELATED ARTICLES

Lung Therapy Targets Derived From Fetal Signaling Pathways

News

Specialized lung cells appear in the developing fetus much earlier than scientists previously thought.

READ MORE

CRISPR Engineered “Invisible” Immune Cells

News

scientists have used the CRISPR-Cas9 gene-editing system to create the first pluripotent stem cells that are functionally "invisible" to the immune system, a feat of biological engineering that, in laboratory studies, prevented rejection of stem cell transplants.

READ MORE

Drug Combo Could Become New Standard Treatment for Advanced Kidney Cancer

News

A combination of two drugs – one of them an immunotherapy agent – could become a new standard, first-line treatment for patients with metastatic kidney cancer, says an investigator from Dana-Farber Cancer Institute, reporting results from a Phase 3 clinical trial.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE